Elsevier logo

Publisher: Elsevier

Related content
Volume 24, Number 1, January 2002

< previous issue | all issues | next issue >

Editorial board
pp. CO2+CO3-CO2+CO3(1)

Ziprasidone: An atypical antipsychotic drug for the treatment of schizophrenia
pp. 21-37(17)
Authors: Stimmel G.L.; Gutierrez M.A.; Lee V.

Bivalirudin: A direct thrombin inhibitor
pp. 38-58(21)
Author: Gladwell T.D.

A multiple-dose pharmacodynamic, safety, and pharmacokinetic comparison of extended- and immediate-release formulations of lovastatin
pp. 112-125(14)
Authors: Davidson M.H.; Lukacsko P.; Sun J.X.; Phillips G.; Walters E.; Sterman A.; Niecestro R.; Friedhoff L.

A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: The MAPAVEL study
pp. 126-138(13)
Authors: MAPAVEL Investigators; Coca A.; Calvo C.; Garcia-Puig J.; Gil-Extremera B.; Aguilera M.T.; de la Sierra A.; Martin-Hidalgo A.; Marin R.

Our love affair with antibiotics: How will it end?
pp. 140-141(2)
Author: Coons S.J.

A retrospective analysis of costs and patterns of treatment for external genital warts in the Netherlands
pp. 183-196(14)
Authors: van der Meijden W.I.; Notowicz A.; Blog F.B.; Langley P.C.

Dear Dr. Walson:
pp. 205-207(3)
Authors: Noel F.; Berringer R.; Patel U.

The author replies:
pp. 207-208(2)
Author: Guthrie R.M.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page